Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Gritstone Oncology

Gritstone Oncology is a privately-held cancer immunotherapy company developing next-generation personalized cancer therapeutics. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunology, and immunotherapy design. The company's initial goal is to identify and deploy therapeutic neo-antigens from individual patients' tumors to develop novel treatments for lung cancer.

Key Contact
Name
Andrew Allen, M.D., Ph.D.
Title
President and CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
10/20/15 $102,000,000 Series A Casdin Capital
Clarus Ventures
Frazier Healthcare
Redmile Group
The Column Group
Transformational Healthcare Opportunity
Versant Ventures
undisclosed
09/07/17 $92,700,000 Series B Alexandria Venture Investments
Clarus Funds
Frazier Healthcare
Lilly Asia Ventures
The Column Group
Trinitas Capital
Versant Ventures
undisclosed